Search
Patexia Research
Case number 1:19-cv-02210

Biogen International GmbH v. Cipla Limited et al > Documents

Date Field Doc. No.Description (Pages)
Jul 1, 2020 13 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Stipulation of Dismissal)(mdb)
Jul 1, 2020 13 Stipulation of Dismissal (2)
Jun 29, 2020 11 Stipulation of Dismissal (2)
Docket Text: STIPULATION of Dismissal Without Prejudice, by Biogen International GmbH. (Balick, Steven)
Jun 29, 2020 12 SO ORDERED (2)
Docket Text: SO ORDERED re [11] Stipulation of Dismissal. ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 6/29/2020. (dlw)
Jun 25, 2020 10 Motion to Dismiss (4)
Docket Text: MOTION to Dismiss Based upon Plaintiff's Complaint for Patent Infringement - filed by Cipla Limited, Cipla USA Inc.. (Attachments: # (1) Exhibit A to Defendants Cipla Limited and Cipla USA Inc.s Motion to Dismiss, # (2) Proposed Order Granting Defendants Cipla Limited and Cipla USA Inc.s Motion to Dismiss)(Cree, Jennifer)
Jun 25, 2020 10 Exhibit A to Defendants Cipla Limited and Cipla USA Inc.s Motion to Dismiss (2)
Jun 25, 2020 10 Proposed Order Granting Defendants Cipla Limited and Cipla USA Inc.s Motion to (1)
Jun 19, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [9] Stipulation and Order Extending Time (Set/Reset Answer Deadlines: Cipla Limited answer due 7/6/2020; Cipla USA Inc. answer due 7/6/2020). ORDERED by Judge Maryellen Noreika on 6/19/2020. (dlw)
Jun 19, 2020 9 Stipulation (1)
Docket Text: Joint STIPULATION and [Proposed] Order Extending Time for Defendants to Respond to Plaintiff's Complaint re Set/Reset Answer Deadline(s) by Cipla Limited, Cipla USA Inc.. (Cree, Jennifer)
Feb 28, 2020 8 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent InvaGen Pharmaceuticals, Inc., Corporate Parent Cipla Limited, Corporate Parent Cipla (EU Limited) for Cipla USA Inc. filed by Cipla Limited, Cipla USA Inc.. (Cree, Jennifer)
Feb 27, 2020 N/A Set/Reset Answer Deadline(s) (0)
Docket Text: Set/Reset Answer Deadlines: Cipla Limited answer due 6/20/2020; Cipla USA Inc. answer due 6/20/2020. (dlw)
Feb 27, 2020 7 Stipulation (2)
Docket Text: STIPULATION Regarding Waiver of Service and Establishment of Answer Deadlines, by Biogen International GmbH. (Balick, Steven)
Feb 20, 2020 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cipla USA Inc. on 2/20/2020. (apk)
Feb 20, 2020 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Biogen International GmbH. Cipla USA Inc. served on 2/20/2020, answer due 3/12/2020. (Balick, Steven)
Feb 14, 2020 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 2/14/2020. (*3 copies) (amf)
Dec 9, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
Dec 4, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Dec 2, 2019 N/A No Summons Issued (0)
Docket Text: No Summons Issued. (myr)
Nov 27, 2019 1 Exhibit A (12)
Nov 27, 2019 1 Civil Cover Sheet (3)
Nov 27, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
Nov 27, 2019 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 18, 2019. Date of Expiration of Patent: June 20, 2020.Thirty Month Stay Deadline: 9/27/2020. (myr)
Nov 27, 2019 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,619,001. (myr)
Nov 27, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc., Corporate Parent Biogen MA Inc., Corporate Parent Biogen Luxembourg Holding Sarl, Corporate Parent Biogen Switzerland Holdings GmbH for Biogen International GmbH filed by Biogen International GmbH. (myr)
Menu